Serum insulin-like growth factor-1 measurements in dogs: Performance characteristics of an automated assay and study of some sources of variation

Canadian Journal of Veterinary Research

Volumn 75, Issue 4, 2011, Pages 312-316

  Tvarijonaviciute, Asta ^a   Tecles, Fernando ^a   Carillo, José M ^b   Rubio, Monica ^b   Ceron, José J ^a  

^a UNIVERSITY OF MURCIA   (Spain)

^b Department of Animal Medicine and Surgery   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; HEMOGLOBIN; HYDROCORTISONE; METHYLPREDNISOLONE; SOMATOMEDIN C; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ARTICLE; AUTOANALYSIS; CHEMOLUMINESCENCE; CIRCADIAN RHYTHM; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIET RESTRICTION; DILUTION; DOG; ENZYME LABELLED CHEMILUMINESCENT IMMUNOMETRIC ASSAY; FEMALE; FOOD INTAKE; HEMOLYSIS; HORMONE RESPONSE; HYDROCORTISONE BLOOD LEVEL; HYPERBILIRUBINEMIA; IMMUNOASSAY; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; SOMATOMEDIN C BLOOD LEVEL; VALIDITY;

ANIMALS; CIRCADIAN RHYTHM; DOGS; FEMALE; IMMUNOENZYME TECHNIQUES; INSULIN-LIKE GROWTH FACTOR I; LUMINESCENT MEASUREMENTS; MALE; METHYLPREDNISOLONE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

CANIS FAMILIARIS;

EID: 80054740956     PISSN: 08309000     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Le Roith D, Bondy C, Yakar S, Liu JL, Butler A. The somatomedin hypothesis. Endocr Rev 2001;22:53-74.
2. Neumann S, Welling H, Thuere S. Insulin-like growth factor I concentration in dogs with inflammatory and neoplastic liver diseases. J Vet Med Assoc 2007;54:612-617.
3. Blanchard G, Nguyen P, Gayet C, Leriche I, Siliart B, Paragon BM. Rapid weight loss with high-protein low-energy diet allows the recovery of ideal body composition and insulin sensitivity in obese dogs. J Nutr 2004;134:2148S-2150S.
4. Queiroga FL, Perez-Alenza D, Silvan G, Peña L, Lopes CS, Illera JC. Serum and intratumoural GH and IGF-1 concentrations: Prognostic factors in the outcome of canine mammary cancer. Res Vet Sci 2010;89:396-403.
5. McGreevy PD, Thompson PC, Pride C, Fawcett A, Grassi T, Jones B. Prevalence of obesity in dogs examined by Australian veterinary practices and the risk factors involved. Vet Record 2005;156:695-702.
6. Feldman BF, Zinkl JG, Jain NC. Schalm's Veterinary Hematology. 5th ed. Ames, Iowa: Blackwell Publ, 2006:20-28.
7. Martínez-Subiela S, Ceron JJ. Effects of hemolysis, lipemia, hyperbilirubinemia, and anticoagulants in canine C-reactive protein, serum amyloid A, and ceruloplasmin assays. Can Vet J 2005;46:625-629.
8. Ishioka K, Hatai H, Komabayashi K, et al. Diurnal variations of serum leptin in dogs: Effects of fasting and re-feeding. Vet J 2005;169:85-90.
9. Martinez-Subiela S, Ginel PJ, Ceron JJ. Effects of different glucocorticoid treatments on serum acute phase proteins in dogs. Vet Rec 2004;154:814-817.
10. Yilmaz Z, Ilcol YO, Golcu E. Serum leptin levels in response to methylprednisolone injection in healthy dogs. Res Vet Sci 2007;82:187-194.
11. Ito Y, Nakachi K, Imai K, et al. Stability of frozen serum levels of insulin-like growth factor-I, insulin-like growth factor-II, insulinlike growth factor binding protein-3, transforming growth factor b, and superoxide dismutase activity for the JACC study. J Epidemiol 2005;15:S67-S73.
12. Guidance for Industry: Bioanalytical Method Validation. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Center for Veterinary Medicine, 2001. Available from www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM070107.pdf Last accessed 2011.
13. Tholen DW, Kroll M, Astles JR. Evaluation of the linearity of quantitative measurement procedures: A statistical approach; approved guideline. NCCLS document EP6-A. NCCLS, Pennsylvania, USA, 2003. Available from http://www.clsi.org/source/orders/free/ep6-a.pdf Last accessed 2011.
14. Belobrajdic DP, Priebe IK, Forbes B, et al. Assesing the potential usefulness of IGF-related peptides and adiponectin for predicting disease risk. Growth Horm IGF Res 2008;18:198-204.
15. Brand-Miller JC, Liu V, Petocz P, Baxter RC. The glycemic index of foods influences postprandial insulin-like growth factorbinding protein responses in lean young subjects. Am J Clin Nutr 2005;82:350-354.
16. Juul A. Serum levels of insulin-like growth factor I and its binding proteins in health and disease. Growth Horm IGF Res 2003;13:113-170.
17. Xu S, Gu X, Pan H, et al. Reference ranges for serum IGF-1 and IGFBP-3 levels in chinese children during childhood and adolescence. Endocr J 2010;57:221-228.
18. Frystyk J, Freda P, Clemmons DR. The current status of IGF-I assay - A 2009 update. Growth Horm IGF Res 2010;20:8-18.
19. Wolthers OD, Juul A, Hansen M, Muller J, Pedersen S. The insulin-like growth factor axis and collagen turnover during prednisolone treatment. Arch Dis Child 1994;71:409-413.
20. Wolthers OD, Hansen M, Juul A, Nielsen HK, Pedersen S. Knemometry, urine cortisol excretion, and measures of the insulin-like growth factor axis and collagen turnover in children treated with inhaled glucocorticosteroids. Pediatr Res 1997;41:44-50.
21. Gourmelen M, Girard F, Binoux M. Serum somatomedin/insulinlike growth factor (IGF) and IGF carrier levels in patients with Cushings syndrome or receiving glucocorticoid therapy. J Clin Endocrinol Metab 1982;54:885-892.
22. Miell JP, Taylor AM, Jones J, et al. The effects of dexamethasone treatment on immunoreactive and bioactive insulin-like growth factors (IGFs) and IGF-binding proteins in normal male volunteers. J Endocrinol 1993;136:525-533.